Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 5 | |
Outperform | 10 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 16 analysts offering 12 month price targets for Nurix Therapeutics Inc have a median target of 31.50, with a high estimate of 41.00 and a low estimate of 16.00. The median estimate represents a 40.81% increase from the last price of 22.37.
High | 83.3% | 41.00 |
Med | 40.8% | 31.50 |
Low | -28.5% | 16.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 13, 2025.
Average growth rate | +0.07% |
Average growth rate | -2.08% |
More ▼
Revenue history & estimates in USD
Average growth rate | -7.87% |
Average growth rate | +65.36% |
More ▼